Study to Assess the Safety and Efficacy of PT010, PT003, and PT009 in Japanese Subjects With COPD Compared With Symbicort® Turbohaler®

NCT03262012 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

416

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

DRUG: BGF MDI (PT010)
DRUG: GFF MDI (PT003)
DRUG: BFF MDI (PT009)
DRUG: Symbicort® Turbohaler® Inhalation Powder

Sponsor

Pearl Therapeutics, Inc.